select trial semaglutide cardiovascular outcomes without diabetes 2023 From drugs... to weight loss drugs... to cardiometabolic drugs? The may mark the beginning of that transition. Where do you think GLP-1 receptor agonists will stand 10 years from Full SELECT Results Affirm CV

Weve already seen strong engagement in the first days since launch, Jones added

Acquiring Viking would instantly give Merck a Phase 3-ready blockbuster and a high-demand oral pill, allowing it to pivot from being an oncology-heavy company to a diversified metabolic leader

Give them a try! Marlon Very kind person and amazing professional

Interestingly, as shown in our transcriptome data, in addition to the pronounced enrichment of genes associated with JA signaling in systemic leaf tissues after GSH treatment, genes responsive to other defense phytohormones such as ethylene and salicylic acid, which are responsible for plant resistance to pathogen infection, are also highly upregulated (Supplementary Data 1), implying that GSH might also act as a signaling molecule to activate the plant systemic immune response